Will the Credits Roll for AMC After This Reopening Delay?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Will the Credits Roll for AMC After This Reopening Delay?

© maksicfoto / Getty Images

The reopening of the U.S. economy has been a relatively slow process, and summer blockbusters may have to wait a little longer to hit theaters after this update from AMC Entertainment Holdings Inc. (NYSE: AMC). The world’s largest movie-theater chain announced that it would further delay its reopening.

Late Thursday, the company said that it now plans to open its U.S. theaters in “mid-to-late August.” AMC was shooting to open on July 30, which also was a delay from its original plan of opening on July 15.

Although the government lockdowns were not entirely successful and were ultimately lifted, AMC is taking the safe route of keeping its theaters closed for longer to help stop the spread of COVID-19. The theater chain initially shuttered its doors in March.

This also comes in reaction to a few major global (anticipated) blockbusters postponing their release dates. “Tenet” from Warner Bros. and Disney’s “Mulan” are two of the main names on this list.

[nativounit]

This past week, AMC announced a debt restructuring plan. It is looking to “restructure a substantial majority” of $2.3 billion of its senior subordinated notes.

Under this plan, the face amount of AMC’s total debt would be reduced by $460 million to $630 million, depending on how many lenders sign on to the agreement. However, there is a plot twist. Bloomberg reported that a group of lenders who are opposed to the debt restructuring are claiming that AMC violated its credit agreement by not providing enough information about this move.

AMC Entertainment stock traded up about 1% at $4.11, in a 52-week range of $1.95 to $12.49. The consensus price target is $3.94.

[recirclink id=725388][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618